Donald A. Kalkofen

Insider Reports History

Entity
Individual
Location
7707 Gateway Boulevard, Suite 140, Newark, CA
Signature
/s/ Donald A. Kalkofen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Donald A. Kalkofen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Protagonist Therapeutics, Inc Chief Financial Officer Common Stock 18.5K $456K $24.63 Feb 15, 2022 Direct
Protagonist Therapeutics, Inc Chief Financial Officer Stock Option (right to buy) 45K Feb 15, 2022 Direct

Insider Reports Filed by Donald A. Kalkofen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PTGX Protagonist Therapeutics, Inc Feb 15, 2022 2 $0 4 Feb 17, 2022 Chief Financial Officer